Abeona Therapeutics Q3 EPS $(0.08) Beats $(0.15) Estimate, Sales $13.491M Miss $16.484M Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.15) by 46.67 percent. This is a 20 percent increase over losses of $(0.10) per share from
Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.15) by 46.67 percent. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $13.491 million which missed the analyst consensus estimate of $16.484 million by 18.16 percent.